SG3 Management’s Zimmer Biomet ZBH Stock Holding History

SG3 Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,060	Closed	-$303K	–	1286
2021 Q2	$322K	Buy	2,060 +1,030	+100%	+$167K	0.01%	734
2021 Q1	$160K	Buy	+1,030	New	+$160K	﹤0.01%	1001
2020 Q3	–	Sell	-2,575	Closed	-$298K	–	1094
2020 Q2	$298K	Buy	+2,575	New	+$297K	0.02%	436

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SG3 Management's ZBH Position: Q3 2021 in Review

SG3 Management sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 2,060 shares — an estimated $303K sold.

SG3 Management first reported a position in ZBH in Q2 2020 and held it in 3 quarters. The position peaked at $322K in Q2 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

SG3 Management reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
SG3 Management sold 2,060 Zimmer Biomet shares in Q3 2021, an estimated $303K.
SG3 Management first reported a position in Zimmer Biomet in Q2 2020 and held it in 3 quarters.
SG3 Management's Zimmer Biomet position peaked at $322K in Q2 2021.
982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.